Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Opsin Biotherapeutics Inc
Profile last edited on: 3/18/2024      CAGE: 8CCX0      UEI: PZA2MCC3MJL9

Business Identifier: Optogenetic neuromodulation for chronic pain
Year Founded
2019
First Award
2023
Latest Award
2023
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1312 Brown Trail
Bedford, TX 76022
   (713) 828-0556
   N/A
   www.opsinbio.com
Location: Single
Congr. District: 24
County: Tarrant

Public Profile

Opsin Biotherapeutics Inc develops opsin gene therapies as an alternative to opioids and electrical spinal cord stimulators to solve chronic pain. Company have licensed a Multi-Characteristic Opsin gene and non-viral delivery method that turns pain-blocking neurons into photoreceptors. These neurons are then activated with a simple red LED. This is the next generation therapy for Spinal Cord Stimulation.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$327,864
Phase II Dollars
$0
Total Awarded
$327,864

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
0 1 NIH $327,864
Project Title: Optogenetic Pain Modulator for non-opioid chronic pain management

Key People / Management

  Robert Benkowski -- CEO

  Samarendra Mohanty

  Darryl Narcisse

  Michael Patterson

Company News

There are no news available.